Author

C. Stender

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Greenstein· 1 shared J. P. Townsend· 1 shared M. Philips· 1 shared S. G. Gaffney· 1 shared V. L. Cannataro· 1 shared Z.-M. Zhao· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Greenstein

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The likelihood of heterogeneity or additional mutation in KRAS or associated oncogenes to compromise targeting of oncogenic KRAS G12C

V. L. Cannataro, S. G. Gaffney, C. Stender, Z.-M. Zhao, M. Philips, A. Greenstein, J. P. Townsend

The study finds no evidence of resistance-conferring mutations in KRAS or downstream genes in KRAS G12C positive tumors at treatment time, and predicts BRAF mutations as likely resistance mechanisms with existing therapies.

bioRxiv · Jun 13, 2017Cancer Biology